- Division of Translational and Clinical Sciences – DTCS
- Oncology 2 – Translational Clinical – OTC
- Study Section:
Dr. Sharon Gubanich is a Scientific Review Officer in the Oncology 2 - Translational and Clinical (OTC) Integrated Review Group.
She is in charge of the Developmental Therapeutics Study Section, which reviews applications addressing the experimental therapy of neoplastic diseases in in vitro and in vivo model systems, including some early-stage, pilot clinical trials. Dr. Gubanich received her Ph.D. in chemistry from the University of Akron. Her research focused on the development of polymeric wound healing accelerators, which were subsequently patented, licensed, and marketed. Before coming to CSR, she conducted postdoctoral studies in pharmacology at Fox Chase Cancer Center focusing on preclinical studies of targeted anticancer agents.